Full-Time

340B Analyst

Posted on 10/6/2025

Shields Health Solutions

Shields Health Solutions

1,001-5,000 employees

Specialty pharmacy services for health systems

Compensation Overview

$75k - $84k/yr

+ Bonus

Boston, MA, USA

In Person

Category
Operations & Logistics (2)
,
Requirements
  • Three or more years of experience.
  • Bachelor’s Degree.
  • Must be highly motivated, results-driven professional who can thrive in a team-oriented environment.
  • Highly collaborative with team members to ensure overall success of the function.
  • Outstanding leadership potential.
  • Growth-mindset.
  • Highly analytical with strong attention to detail.
  • Exceptional technical skills and ability to navigate computer software, including medication management software, healthcare billing systems, electronic medical records, 340B third party administrators, pharmacy management and dispensing systems, and Microsoft applications.
  • Values-oriented, data-driven decision-making style.
  • Ability to distill complex issues into structured frameworks and concrete action plans.
  • Ambitious, reliable, self-starter who is able to work independently, with limited oversight from managers.
  • Effective at multi-tasking; someone who enjoys and thrives wearing multiple hats.
  • Outstanding written and verbal communication skills.
  • Enthusiastic and service-oriented.
  • Entrepreneurial attitude - willingness to roll up sleeves to make things happen quickly and create value.
Responsibilities
  • Develop a thorough understanding of the 340B program, monitor recent legislative changes or proposed 340B pharmacy regulations, and communicate current 340B trends and interpretations directly affecting SHS health system partners
  • Work directly with health system 340B Compliance/Operations teams to monitor 340B Program compliance, audit non-340B prescriptions, identify new margin enhancement opportunities, and implement new 340B expansion strategies
  • Develop an innate knowledge of all SHS partner pharmacy dispensing systems, EMRs, as well as various 340B platforms to monitor 340B activity
  • Review Hospital Medicare Cost Reports and identify 340B eligible departments for new partner opportunities
  • Track 340B Program savings generated by SHS health system partners
  • Assist in implementing new 340B Third-Party Administrator (TPA) platforms for new hospital clients
  • Develop and/or update 340B policies and procedures utilized by SHS partners to reflect 340B Program best practices and ensure partner 340B Program qualifications are met and maintained
  • Assess and analyze each customers’ wholesaler accounts to ensure appropriate pricing is reflected for all medications
  • Review each customer’s wholesaler catalog to confirm access to Limited Distribution Drugs (LDD) at all price points (340B & Non-340B)
  • Ability to track LDD products dispensed as well as on-hand inventory levels in order to develop required reports by select PhRMA manufacturers
  • Monitor 340B pricing restrictions issued by manufacturers and communicate SHS partner impact/SHS contribution profit
  • Develop strategies in collaboration with SHS partners to consistently update eligible provider listings and data extracts utilized to identify 340B prescriptions
  • Manage and track partner pharmacy activity dispensed through contract pharmacy arrangements. Create monthly reports to identify 340B revenue, dispensing fees, and corresponding COGS dispensed via contract pharmacy
  • Maintain knowledge of pharmacy billing requirements for each State Medicaid agency
  • Create daily reports to identify 340B eligible Managed Medicaid prescriptions and ensure appropriate 340B modifiers are included at the claim level to mitigate the risk of duplicate discounts
  • Develop monthly reports and reprocess Medicaid Fee-for-Service prescriptions to reflect required acquisition cost reimbursement
  • Perform weekly audits of non-340b prescriptions dispensed by partner pharmacy locations and gather 340B supporting documentation from the EMR to identify 340B optimization opportunities
  • Collaborate with 340B Compliance teams and pharmacy liaisons to assess 340B eligibility for patients in cases in which the 340B price is the only procurement method
  • Review and assess pharmacy purchasing trends by client in order to identify ordering inconsistencies or areas to improve purchasing efficiencies
  • Evaluate available pricing offered to each client and identify cost savings opportunities via cheaper medication alternatives
  • Collaborate with Shields Trade Relations group to obtain 340B pricing for drugs designated as an orphan drug for clients subject to the Orphan Drug Exclusion
  • Develop and update 340B Program reporting detailing 340B volume, financial value, and other 340B KPIs as needed
  • Expand professional development through 340B related classes and seminars, current publications, and 340B Coalition conference attendance
Desired Qualifications
  • National Pharmacy Technician license preferred.
  • Apexus 340B Certification preferred.
Shields Health Solutions

Shields Health Solutions

View

Shields Health Solutions provides integrated specialty pharmacy services for health systems to improve patient outcomes and drive growth. It collaborates with 75 health systems, including academic medical centers and community hospitals across 47 states, to deliver medication management, patient support programs, and care coordination for patients with chronic and complex diseases. The company works by partnering with clinicians and healthcare providers to manage specialty medications, optimize clinical outcomes, and make high-cost therapies more accessible and affordable. What sets Shields apart is its extensive network of health-system partnerships and its focus on therapy management and coordination within the hospital ecosystem, rather than operating as a standalone retail pharmacy. The goal is to help health systems expand access to specialty care, improve patient outcomes, and grow through integrated pharmacy services.

Company Size

1,001-5,000

Company Stage

Growth Equity (Non-Venture Capital)

Total Funding

$4.5B

Headquarters

Quincy, Massachusetts

Founded

2012

Simplify Jobs

Simplify's Take

What believers are saying

  • Evernorth's $3.5 billion investment provides substantial capital for expansion and innovation.
  • AI-enabled workflows with Foundation Health strengthen operational efficiency in specialty pharmacy.
  • Expanding partnerships with Duke Health and Lakeland Regional Health drive market penetration.

What critics are saying

  • Evernorth's preferred stock investment grants controlling influence over Shields' strategic decisions.
  • Evernorth redirects limited distribution drug access to Cigna's Accredo, marginalizing health system partners.
  • Walgreens divestiture severs pharmacy infrastructure support, inflating operational costs 20-30% immediately.

What makes Shields Health Solutions unique

  • Integrated specialty pharmacy model serves 80+ health systems across 47 states nationwide.
  • Proprietary TelemetryRx platform identifies eligible patients and provides standardized data reporting.
  • Clinical model proven to lower total cost of care by 13%.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Hybrid Work Options

Annual Performance Bonus

Company News

Shields Health Solutions
Mar 17th, 2026
Shields and Foundation Health partner to bring AI to a rapidly evolving specialty pharmacy landscape.

Shields and Foundation Health partner to bring AI to a rapidly evolving specialty pharmacy landscape. As the specialty pharmacy landscape rapidly changes, Shields Health Solutions is taking a thoughtful approach to innovation. In Becker's Hospital Review, Shields shares why it partnered with Foundation Health to develop AI-enabled workflows designed to strengthen operational efficiency and future-ready pharmacy models. Read the full article at Becker's Hospital Review.

Central Florida Health News
Nov 12th, 2025
Shields Health Solutions, Lakeland Regional Health Collaborate to Enhance Patient Access to Specialty Pharmacy Care

Shields Health Solutions, Lakeland Regional Health collaborate to enhance patient access to specialty pharmacy care. The partnership will support patients through personalized care, medications, and coordination. STOUGHTON, Mass. & LAKELAND, Fla. (November 12, 2025) - Shields Health Solutions (Shields), the premier specialty pharmacy accelerator in the country, has partnered with Lakeland Regional Health, one of Florida's leading healthcare providers, to improve access to specialty medications for patients managing chronic and complex health conditions. This enhanced collaboration is designed to support patients who rely on specialty medications to treat conditions such as cancer, multiple sclerosis, and autoimmune diseases. It will also strengthen care coordination across Lakeland Regional Health's provider network by integrating Shields' care model and expertise in specialty pharmacy. "Lakeland Regional Health is known for delivering compassionate, high-quality care to patients across Central Florida," said Michael Ham, CEO of Shields Health Solutions. "We're proud to support their teams by expanding access to specialty medications and helping patients manage complex therapies more affordably and effectively." Through this partnership, patients will benefit from personalized support services, including help navigating insurance coverage and financial assistance programs, which aim to reduce out-of-pocket costs, improve medication adherence, and ensure timely access to critical therapies. The initial focus of the collaboration will be on oncology and rheumatology with plans to expand into additional specialties over time. Shields currently partners with nearly 80 health systems nationwide, helping patients receive medications faster, reduce co-pays, and improve health outcomes. "At Lakeland Regional Health, we are committed to removing barriers to care and ensuring our patients have access to the treatments they need," said Ana Kalman, SVP, Chief Information Officer, Chief Operating Officer and Medical Center COO of Lakeland Regional Health. "Partnering with Shields allows us to enhance our specialty pharmacy services and deliver even greater value to our community." For more information, visit www.shieldshealthsolutions.com.

Benzinga
Sep 2nd, 2025
Analyst Favors Cigna, Alignment Healthcare, Cautious On Peers

Evernorth Health Services announced on Tuesday a $3.5 billion investment in Shields Health Solutions, a specialty pharmacy management company.

Surperformance
Sep 2nd, 2025
Cigna's Evernorth invests $3.5B in Shields

Cigna's unit, Evernorth Health, will invest $3.5 billion in Shields Health to enhance its specialty pharmacy business. This investment follows Shields' transition to a private company after Sycamore Partners acquired its former parent, Walgreens Boots Alliance, for $10 billion. Evernorth, which operates Accredo, aims to meet the growing demand for specialty medications. The investment is in preferred stock and won't impact Cigna's 2025 profit forecast.

PR Newswire
Sep 2nd, 2025
Evernorth Health Services Announces Investment in Shields Health Solutions

/PRNewswire/ -- Evernorth Health Services ("Evernorth"), a subsidiary of The Cigna Group (NYSE: CI), today announced a $3.5 billion investment in Shields...

INACTIVE